|
|
Article: Research and Markets: Stakeholder Insight: Neuropathic Pain - Comparative Overview of Treatment Preferences Across the Seven Major Markets.
- Article from:
- Business Wire
- Article date:
- April 22, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors
DUBLIN, Ireland--(BUSINESS WIRE)--April 22, 2004
The Neuropathic Pain Market Continues to Grow for the next Ten
Years due to Increased Public and Physician Awareness and New Drug
Launches including Generic Gabapentin
Research and Markets (http://www.researchandmarkets.com) has announced the addition of Stakeholder Insight: Neuropathic Pain - Comparative Overview of Treatment Preferences Across the Seven Major Markets to their offering.
Introduction